...
首页> 外文期刊>Translational research: the journal of laboratory and clinical medicine >Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
【24h】

Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.

机译:白细胞介素6基因多态性和更快地进展为慢性肾小球肾炎的终末期肾衰竭。

获取原文
获取原文并翻译 | 示例
           

摘要

Interleukin-6 (IL-6) is a multifunctional cytokine produced by different cell types, including monocytes, lymphocytes, endothelial and mesangial cells. Deregulated production of IL-6 was found to be involved in mesangial proliferative glomerulonephritis. We investigated whether the single nucleotide polymorphism (SNP) in the promoter region of the IL-6 gene is associated with a development of chronic glomerulonephritis (CGN). The study group consisted of 541 patients with CGN. Of those 338 already progressed to ESRD. The control group involved 253 healthy individuals. All subjects were genotyped for the -634 C/G polymorphism of the IL-6 gene by polymerase chain reaction (PCR). PCR product was digested with BsrBI restriction endonuclease and analyzed on 3% agarose. The allele and genotype frequencies were similar between CGN patients in a pre-dialysis stage and control subjects. Significantly increased frequency of the G allele was observed in the ESRD patients (13% vs. 6% in pre-dialysis stage, P < 0.01). After dividing ESRD patients according to time from reported disease onset to ESRD, those with time < or =5 years showed even higher G allele frequency (21% vs. 13% in entire ESRD group). Interestingly, most of the GG homozygotes were in this faster progressing group. Both subgroups were comparable for sex, age, BMI, total cholesterol and serum creatinine. The multivariate logistic regression analysis revealed that the IL-6 genotype with the G allele was an independent risk factor of progression to ESRD (P < 0.001). Our results indicate that the IL-6 -634 G/C polymorphism may be a possible risk factor for faster progression of chronic glomerulonephritis to ESRD. It is also possible that this polymorphism is in linkage disequilibrium with another functional polymorphism in the II-6 gene or its vicinity.
机译:白细胞介素-6(IL-6)是由不同类型的细胞产生的多功能细胞因子,包括单核细胞,淋巴细胞,内皮细胞和肾小球膜细胞。发现IL-6的生产失调与肾小球膜增生性肾小球肾炎有关。我们调查了IL-6基因启动子区域中的单核苷酸多态性(SNP)是否与慢性肾小球肾炎(CGN)的发展有关。该研究组由541名CGN患者组成。在这338个中,已经进入了ESRD。对照组包括253名健康个体。通过聚合酶链反应(PCR)对所有受试者的IL-6基因的-634 C / G多态性进行基因分型。 PCR产物用BsrBI限制性核酸内切酶消化,并在3%琼脂糖上分析。透析前阶段的CGN患者与对照组之间的等位基因和基因型频率相似。在ESRD患者中观察到G等位基因的频率显着增加(透析前阶段为13%比6%,P <0.01)。根据报告的疾病发作至ESRD的时间对ESRD患者进行划分后,时间<或= 5年的患者显示更高的G等位基因频率(21%相对于整个ESRD组为13%)。有趣的是,大多数GG纯合子都在这个进展较快的组中。这两个亚组在性别,年龄,BMI,总胆固醇和血清肌酐方面均具有可比性。多元logistic回归分析显示,具有G等位基因的IL-6基因型是进展为ESRD的独立危险因素(P <0.001)。我们的结果表明,IL-6 -634 G / C多态性可能是慢性肾小球肾炎向ESRD更快发展的可能危险因素。该多态性也可能与II-6基因或其附近的另一个功能性多态性处于连锁不平衡状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号